Targeted exercise relieves sciatica pain

April 9, 2012
Targeted exercise relieves sciatica pain

(HealthDay) -- Active conservative symptom-guided therapy for severe sciatica can safely reduce pain and improve neurological function at a rate that matches or surpasses outcomes from common higher-cost surgical interventions, according to a Danish study published in the April 1 issue of Spine.

Hanne B. Albert, P.T., Ph.D., and Claus Manniche, M.D., Ph.D., of the University of Southern Denmark in Ringe, conducted a prospective, single-blind, randomized, controlled study of 181 consecutive patients with severe sciatica. To evaluate the efficacy of active conservative treatments for relief of severe sciatica caused by a herniated disc, patients were randomly assigned to a group given symptom-guided exercise that targeted below-the-knee pain or to a group given sham exercises that improved general . Each group also received information and advice to stay active.

The researchers found that both groups of patients experienced similar reductions in leg pain at the end of treatment and at one year. For patients with severe sciatica, the symptom-guided patient exercises were superior to sham activities for improving most neurological signs after eight weeks of treatment and at one-year follow-up.

"Active was effective for patients who had symptoms and clinical findings that would normally qualify them for surgery," the authors write.

Explore further: Surgical treatment within six months of lumbar disc herniation

More information: Abstract
Full Text

Related Stories

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.